Cyclo Therapeutics Inc.

NASDAQ: CYTH · Real-Time Price · USD
0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM

Cyclo Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-20.06M -15.45M -14.29M
Depreciation & Amortization
19.28K 19.48K 16.83K
Stock-Based Compensation
736.91K 513.57K 470.88K
Other Working Capital
-62.29K -248.56K -297
Other Non-Cash Items
52.92K -148.25K 21.93K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
3.06M -48.15K -1.23M
Operating Cash Flow
-16.19M -15.11M -15.01M
Capital Expenditures
-2.42K -15.09K -22.5K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a 53.26K 37.32K
Investing Cash Flow
-2.42K 38.17K 14.82K
Debt Repayment
n/a 6.78K -6.78K
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
14.15M n/a n/a
Financial Cash Flow
23.89M 6.78K 18.76M
Net Cash Flow
7.7M -15.07M 3.77M
Free Cash Flow
-16.19M -15.13M -15.03M